Bayer’s Betaferon approved in China for Treatment of Multiple Sclerosis

Bayer Schering Pharma AG announced Tuesday that the Chinese State Food and Drug Administration has approved Betaferon (interferon beta-1b) therapy for patients with relapsing-remitting multiple sclerosis.
Insciences